Taiho Pharmaceutical News and Activities

Taiho Pharmaceutical is owned by Otsuka Holdings.

Otsuka Holdings is one of the...

• Forbes Global 2000 (#654);
• Nikkei 225;
• TOB Iconic 10,000;
• Topix.

Otsuka Holdings is a company listed under the stock ticker 4578 (JP).

Otsuka Holdings has a direct presence in 11 countries.

Otsuka Holdings has 23 subsidiaries including Araris Biotech, Cambridge Isotope Laboratories and Interpharma.

They are in:

• Pharmaceuticals46%
• Medical Equipment29%
• Other25%

Acquisition, funding and merger involving Otsuka Holdings.

• Taiho Pharmaceutical has announced the acquisition of Araris Biotech  (posted on April 3 2025).

View the org chart displaying its 41 main executives

Most searched biographies at Taiho Pharmaceutical

• Masayuki Kobayashi, President and Representative Director
• Tatsuya Nakajima, Director
• Nobuyuki Hashimoto, Director

Create your alert
to follow the executive moves at Taiho Pharmaceutical.

Otsuka Holdings has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by Taiho Pharmaceutical

Social media about Taiho Pharmaceutical

• Taiho Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Taiho Pharmaceutical on LinkedIn, X (Twitter) & YouTube